Linda K. Curtiss
#155,079
Most Influential Person Now
Linda K. Curtiss's AcademicInfluence.com Rankings
Linda K. Curtissbiology Degrees
Biology
#11898
World Rank
#15331
Historical Rank
Molecular Biology
#1879
World Rank
#1908
Historical Rank
Biochemistry
#1995
World Rank
#2136
Historical Rank

Download Badge
Biology
Why Is Linda K. Curtiss Influential?
(Suggest an Edit or Addition)Linda K. Curtiss's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis (2001) (1176)
- Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. (2000) (691)
- Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. (1990) (628)
- A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. (2001) (617)
- Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. (1996) (577)
- Modulation of atherosclerosis in mice by Toll-like receptor 2. (2005) (561)
- A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. (1998) (560)
- Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. (1999) (540)
- IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. (2004) (453)
- Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor–Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes (2002) (378)
- Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. (1996) (367)
- Apolipoprotein E and atherosclerosis. (2000) (263)
- Regulated Expression of the Apolipoprotein E/C-I/C-IV/C-II Gene Cluster in Murine and Human Macrophages (2002) (251)
- Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events (2008) (229)
- Percutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein(a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein (2004) (229)
- High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. (1999) (225)
- Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma (2010) (224)
- Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. (1995) (213)
- HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. (2015) (212)
- Plasma Apolipoproteins AI, AII, B, CI, and E Are Glucosylated in Hyperglycemic Diabetic Subjects (1985) (209)
- Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. (2006) (202)
- PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis (2008) (193)
- Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. (1995) (190)
- Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. (1976) (173)
- Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. (1994) (169)
- Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. (1984) (169)
- Emerging role of Toll-like receptors in atherosclerosis Published, JLR Papers in Press, November 1, 2008. (2009) (157)
- Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. (1986) (153)
- What Is So Special About Apolipoprotein AI in Reverse Cholesterol Transport? (2006) (153)
- Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. (2012) (151)
- Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo (1999) (142)
- The Mechanism of the Remodeling of High Density Lipoproteins by Phospholipid Transfer Protein* (2001) (140)
- Arteriosclerosis, Thrombosis, and Vascular Biology. (2016) (133)
- Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I (2010) (130)
- Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. (1994) (127)
- A Minimally Lipidated Form of Cell-derived Apolipoprotein E Exhibits Isoform-specific Stimulation of Neurite Outgrowth in the Absence of Exogenous Lipids or Lipoproteins* (1998) (125)
- The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase (2007) (122)
- Conservation of the Low Density Lipoprotein Receptor‐Binding Domain of Apoprotein B (1986) (111)
- Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies. (1982) (111)
- Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. (1991) (109)
- Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions (2012) (105)
- Leukocyte Transglutaminase 2 Expression Limits Atherosclerotic Lesion Size (2005) (104)
- Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis Published, JLR Papers in Press, January 16, 2005. DOI 10.1194/jlr.R400015-JLR200 (2005) (103)
- Chemokines and atherosclerosis. (1998) (102)
- Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products. (1997) (102)
- The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. (2000) (101)
- New mechanism for foam cell generation in atherosclerotic lesions. (1987) (100)
- Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. (1993) (100)
- Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity (1984) (97)
- Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. (1986) (96)
- Interaction of plasma lipoproteins with human platelets. (1984) (96)
- Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia. (1987) (94)
- Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms. (1993) (94)
- Immunoelectron microscopy of low density lipoproteins yields a ribbon and bow model for the conformation of apolipoprotein B on the lipoprotein surface. (1995) (90)
- Effect of γ-Irradiation and Bone Marrow Transplantation on Atherosclerosis in LDL Receptor-Deficient Mice (2001) (89)
- A single copy of apolipoprotein B-48 is present on the human chylomicron remnant. (1997) (89)
- A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins. (1983) (88)
- Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. (1981) (86)
- Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. (1999) (83)
- Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells. (1994) (82)
- Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100. (1987) (78)
- Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor‐related protein/α2‐macroglobulin receptor (1993) (77)
- Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals. (1984) (76)
- Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells. (1981) (74)
- Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells Published, JLR Papers in Press, May 1, 2003. DOI 10.1194/jlr.M200281-JLR200 (2003) (71)
- Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. (1997) (71)
- MyD88 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Independent of Signaling Through Toll-Like Receptors 2 and 4 (2011) (71)
- DNA Vaccination Against VEGF Receptor 2 Reduces Atherosclerosis in LDL Receptor–Deficient Mice (2007) (70)
- The Hydrophobic Face Orientation of Apolipoprotein A-I Amphipathic Helix Domain 143–164 Regulates Lecithin:Cholesterol Acyltransferase Activation* (1998) (70)
- Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B. (1985) (69)
- Immunochemical heterogeneity of human plasma apolipoprotein B. II. Expression of apolipoprotein B epitopes on native lipoproteins. (1982) (68)
- Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. (1994) (68)
- Apoprotein E-rich high density lipoproteins inhibit ovarian androgen synthesis. (1988) (68)
- Localization of an apolipoprotein A-I epitope critical for activation of lecithin-cholesterol acyltransferase. (1991) (67)
- Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in abetalipoproteinemia. (1996) (66)
- ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages. (1999) (65)
- Mimicry of high-density lipoprotein: functional peptide-lipid nanoparticles based on multivalent peptide constructs. (2013) (64)
- Parallel expression of the MB19 genetic polymorphism in apoprotein B-100 and apoprotein B-48. Evidence that both apoproteins are products of the same gene. (1986) (64)
- THP-1 cells form foam cells in response to coculture with lipoproteins but not platelets. (1991) (64)
- Interaction of Lp(a) with Plasminogen Binding Sites on Cells (1995) (63)
- Inflammation in Atherosclerosis: Lesion Formation in LDL Receptor–Deficient Mice With Perforin and Lystbeige Mutations (2002) (62)
- ApoE in atherosclerosis : a protein with multiple hats. (2000) (62)
- Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein. (1978) (61)
- Anti-apoprotein B monoclonal antibodies detect human low density lipoprotein polymorphism. (1984) (60)
- A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides. (1985) (58)
- Increased Production of Apolipoprotein B-containing Lipoproteins in the Absence of Hyperlipidemia in Transgenic Mice Expressing Cholesterol 7α-Hydroxylase* (2001) (58)
- In vivo suppression of the primary immune response by a species of low density serum lipoprotein. (1977) (58)
- The NH2-terminal Region of Apolipoprotein B Is Sufficient for Lipoprotein Association with Glycosaminoglycans* (1998) (58)
- Atheroprotective Potential of Macrophage-Derived Phospholipid Transfer Protein in Low-Density Lipoprotein Receptor–Deficient Mice Is Overcome by Apolipoprotein AI Overexpression (2006) (58)
- Lipoprotein Lipase Association with Lipoproteins Involves Protein-Protein Interaction with Apolipoprotein B (*) (1995) (57)
- Subdomain Chimeras of Hepatic Lipase and Lipoprotein Lipase (1998) (57)
- An amino-terminal fragment of apolipoprotein B binds to lipoprotein lipase and may facilitate its binding to endothelial cells. (1994) (56)
- Mapping apolipoprotein B on the low density lipoprotein surface by immunoelectron microscopy. (1991) (55)
- Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I Published, JLR Papers in Press, February 1, 2005. DOI 10.1194/jlr.M400212-JLR200 (2005) (53)
- High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins. (2005) (50)
- Apolipoprotein A-II Inhibits High Density Lipoprotein Remodeling and Lipid-poor Apolipoprotein A-I Formation* (2003) (50)
- Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3). (2004) (49)
- Alteration in Apolipoprotein A-I 22-Mer Repeat Order Results in a Decrease in Lecithin:Cholesterol Acyltransferase Reactivity* (1997) (49)
- Immunochemical heterogeneity of human plasma high density lipoproteins. Identification with apolipoprotein A-I- and A-II-specific monoclonal antibodies. (1985) (48)
- Reversing atherosclerosis? (2009) (48)
- Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I. (1997) (48)
- Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists[S] (2012) (47)
- Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor. (1995) (47)
- Toll-like receptors and atherosclerosis (2006) (47)
- Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. (1994) (46)
- Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein. (1994) (45)
- Role of leukocyte-specific LDL receptors on plasma lipoprotein cholesterol and atherosclerosis in mice. (1997) (43)
- A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor. (1991) (43)
- Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Δ6 and Wild-type ApoA-I in Transgenic Mice* (2000) (41)
- Interaction of NADPH oxidase 1 with Toll-like receptor 2 induces migration of smooth muscle cells. (2013) (41)
- Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice. (1999) (40)
- International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B (1990) (40)
- Atherosclerosis in Mice Is Not Affected by a Reduction in Tissue Factor Expression (2005) (39)
- Effect of gamma-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice. (2001) (39)
- An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo. (1998) (38)
- Participation of innate and acquired immunity in atherosclerosis (2000) (38)
- Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100. (1989) (38)
- Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice. (2005) (37)
- The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice (2013) (37)
- Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein. (1979) (37)
- Quantitation of plasma apolipoprotein A-I using two monoclonal antibodies in an enzyme-linked immunosorbent assay. (1988) (36)
- The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis. (2007) (36)
- Leukocyte CD11b expression is not essential for the development of atherosclerosis in mice. (2000) (36)
- Only multimers of a synthetic peptide of human apolipoprotein E are biologically active. (1991) (36)
- Localization of two epitopes of apolipoprotein A-I that are exposed on human high density lipoproteins using monoclonal antibodies and synthetic peptides. (1988) (34)
- Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation. (1977) (34)
- Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase. (1992) (33)
- Is two out of three enough for ABCG1? (2006) (33)
- 13C NMR evidence that substitution of glutamine for arginine 3500 in familial defective apolipoprotein B-100 disrupts the conformation of the receptor-binding domain. (1991) (33)
- Monoclonal antibody detects Ag polymorphism of apolipoprotein B (1986) (33)
- Apolipoprotein B allotypes MB19(1) and MB19(2) in subjects with coronary artery disease and hypercholesterolemia. (1987) (33)
- Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling. (2002) (32)
- In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I[S] (2014) (32)
- Lipoprotein B37, a naturally occurring lipoprotein containing the amino-terminal portion of apolipoprotein B100, does not bind to the apolipoprotein B,E (low density lipoprotein) receptor. (1987) (31)
- Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice. (2006) (31)
- Immunoregulatory plasma low density lipoprotein: the biologic activity and receptor-binding specificity is independent of neutral lipids. (1981) (31)
- Plasma lipoproteins with bioregulatory properties including the capacity to regulate lymphocyte function and the immune response. (1981) (31)
- Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites[S] (2011) (30)
- Interaction between ApoB and Hepatic Lipase Mediates the Uptake of ApoB-containing Lipoproteins* (1998) (30)
- Ag(c): Recognition by a Monoclonal Antibody (1986) (28)
- Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid. (1998) (28)
- Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus. (1981) (28)
- Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency Published, JLR Papers in Press, October 10, 2007. (2008) (27)
- Toll-like receptors in atherosclerosis. (2007) (27)
- The biologic activity of the immunoregulatory lipoprotein, LDL-In is independent of its free fatty acid content. (1981) (25)
- Apolipoprotein B mediates the capacity of low density lipoprotein to suppress neutrophil stimulation by particulates. (1986) (22)
- Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis. (1996) (22)
- Stoichiometric binding of apolipoprotein B-specific monoclonal antibodies to low density lipoproteins. (1985) (22)
- Localization of Coliphage MS2 A-Protein (1974) (20)
- Low density lipoprotein inhibits the physical interaction of phlogistic crystals and inflammatory cells. (1986) (20)
- An apolipoprotein E synthetic peptide selectively modulates the transcription of the gene for rat ovarian theca and interstitial cell P450 17alpha-hydroxylase, C17-20 lyase. (1998) (20)
- Participation of macrophages in atherosclerotic lesion morphology in LDLr−/− mices⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional two figures. Published, JLR Papers in Press, June 1, 2004. DOI 10.1194/jlr.M400036-JLR200 (2004) (20)
- Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects. (1994) (18)
- TLR2 in murine atherosclerosis (2008) (18)
- Detection of two apolipoprotein B species (apoBc and apoBg) by a monoclonal antibody. (1987) (18)
- Effect of long chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine on the interaction with recombinant high density lipoprotein apolipoprotein A-I. (1998) (17)
- Influence of the immunoregulatory serum lipoprotein LDL-In on the in vivo proliferation and differentiation of antigen-binding and antibody-secreting lymphocytes during a primary immune response. (1980) (17)
- Identification of apolipoprotein B100 polymorphisms that affect low-density lipoprotein metabolism: description of a new approach involving monoclonal antibodies and dynamic light scattering. (1995) (17)
- Erratum: Differential expression of oxidation-specifi c epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions (J. Lipid Res. (2012) 53 (2773-2790) (2014) (16)
- Platelet-enhanced apolipoprotein E production by human macrophages: a possible role in atherosclerosis. (1988) (16)
- Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47. (1994) (16)
- Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice. (1997) (15)
- Dietary fish oil-induced decrease in low density lipoprotein binding to fibroblasts is mediated by apolipoprotein E. (1994) (15)
- A method for localizing the early products of nonenzymatic glycosylation in fixed tissue. (1989) (14)
- Differences in the characteristics of inhibition of lymphocyte stimulation by 25-hydroxycholesterol and by the immunoregulatory serum lipoprotein LDL-In. (1980) (13)
- MyD 88 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Independent of Signaling Through Toll-Like Receptors 2 and 4 (2011) (13)
- Comparison of the Effects of Apo(a) Kringle IV-10 and Plasminogen Kringles on the Interactions of Lipoprotein(a) with Regulatory Molecules (1999) (13)
- Interaction of lipoprotein (a) with the extracellular matrix (1998) (12)
- Effects of chronic mental stress and atherogenic diet on the immune inflammatory environment in mouse aorta (2011) (12)
- Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation. (1984) (12)
- Regulatory roles of T mu and T gamma cells in the collaborative cellular initiation of the extrinsic coagulation pathway by bacterial lipopolysaccharide. (1985) (12)
- Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q. (1986) (12)
- Platelet-mediated foam cell formation in atherosclerosis. (1990) (11)
- Disruption of tissue-specific fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in mice. (2009) (11)
- THE BIOREGULATORY PROPERTIES OF SERUM LOW DENSITY LIPOPROTEIN INHIBITOR (LDL-IN) ON THE GENERATION OF KILLER T CELLS (1977) (11)
- Dissociation of LPL and LDL: effects of lipoproteins and anti-apoB antibodies. (1997) (10)
- Selection of monoclonal antibodies for linear epitopes of an apolipoprotein yields antibodies with comparable affinity for lipid-free and lipid-associated apolipoprotein. (1996) (10)
- The Immunosuppressive Activity of Plasmic Degradation Products of Human Fibrinogen (1977) (10)
- Activation of C1 by monoclonal antibodies directed against C1q. (1985) (9)
- Modulation of peripheral blood mononuclear cell cyclic adenosine monophosphate levels by human very low density lipoprotein (1981) (9)
- Studying low-density lipoprotein-monoclonal antibody complexes using dynamic laser light scattering and analytical ultracentrifugation. (1999) (8)
- Identification and properties of glycated monoclonal IgA that affect the fructosamine assay. (2003) (8)
- Monocytes can be induced by lipo poly saccharide stimulated t cells to express factor vii activity (1983) (6)
- Application of Monoclonal Antibodies to Issues of Plasma Lipoprotein Structure and Function (1985) (5)
- Arteriosclerosis, Thrombosis, and Vascular Biology. (2017) (5)
- High-level lipoprotein [a] expression in transgenic mice: Published, JLR Papers in Press, January 16, 2005. DOI 10.1194/jlr.M400467-JLR200evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins (2005) (4)
- SUPPRESSION OF THE IN VIVO HUMORAL IMMUNE RESPONSE BY A SPECIES OF NORMAN HUMAN SERUM LOW DENSITY LIPOPROTEIN (1977) (4)
- Effect of g-Irradiation and Bone Marrow Transplantation on Atherosclerosis in LDL Receptor–Deficient Mice (2001) (4)
- The relative immunodominance of haptenic determinants on a complex hapten phage conjugate. (1975) (3)
- Expression of the Lyst(beige) mutation is atheroprotective in chow-fed apolipoprotein E-deficient mice. (2008) (3)
- Kinetics of C1 activation by a monoclonal anti-C1q antibody and its (Fab)2 fragments. (1987) (3)
- Glycosaminoglycans alter the capacity of low density lipoprotein to bind to monosodium urate crystals. (1990) (3)
- International Federation of Clinical Chemistry (IFCC) Scientific Division. Committee on Apolipoproteins, Working Group on Antibody Reagents. Selection and characterization of monoclonal antibodies for measuring plasma levels of apolipoproteins A-I and B. (1990) (3)
- [19] Immunochemical isolation and identification of glucosylated apolipoproteins (1986) (2)
- Immunochemical isolation and identification of glucosylated apolipoproteins. (1986) (2)
- Expression of the Lystbeige mutation is atheroprotective in chow-fed apolipoprotein E-deficient mices⃞s⃞ The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of two figures. Published, JLR Papers in Press, November 2, 2007. (2008) (2)
- The use of monoclonal antibodies to detect genetic polymorphism: application to apolipoprotein B. (1985) (2)
- Feasibility of an immunoassay for mevalonolactone. (1997) (2)
- IS144 The Role of IL-8 and Its Receptor CXCR2 in Atherosclerosis (2000) (1)
- 4P-0998 Pathophysiologic interrelationship of OxLDL and Lp(a) in human coronary plaque disruption and acute coronary syndromes (2003) (1)
- Abstract: 143 ENDOTHELIAL CELL TOLL-LIKE RECEPTOR EXPRESSION AND MACROPHAGE ACCUMULATION ARE INCREASED ONLY IN REGIONS OF DISTURBED BLOOD FLOW IN THE MOUSE AORTA (2009) (1)
- 4.P.327 Locally available apolipoprotein AI reduces cholesterol accumulation in the atherosclerotic lesion (1997) (1)
- Bone marrow-derived HL mitigates bone marrow-derived CETP-mediated decreases in HDL in mice globally deficient in HL and the LDLr (2014) (1)
- Influence of triglyceride enrichment on the remodelling of high density lipoproteins by PLTP (2000) (1)
- The influence of antigen on a model for analysis of multiple coordinate events associated with the primary immune response. (1979) (1)
- A RECEPTOR FOR NORMAL HUMAN SERUM LOW DENSITY LIPOPROTEINS ON PERIPHERAL BLOOD LYMPHOCYTES (1977) (1)
- Purification and characterization of coliphage MS2 hapten conjugates. (1973) (1)
- Abstract 1356: Endothelial Cell Toll-Like Receptor 2 Expression And Macrophage Number Are Increased At Sites Of Disturbed Blood Flow In The Mouse Aorta (2006) (0)
- Monoclonal antibodies specific for apolipoprotein B, which are produced by two hybridomas. (1987) (0)
- produced two new hybridoma apolipoprotein B specific monoclonal antibodies (1987) (0)
- Abstract: S2-4 OPTICAL ANALYSIS OF TLR FUNCTION IN ATHEROMA (2009) (0)
- Congratulations to Dr Elizabeth G. Nabel (2005) (0)
- Effect of &ggr;-Irradiation and Bone Marrow Transplantation on Atherosclerosis in LDL Receptor-Deficient Mice (2001) (0)
- Monoclonal antibody b 19 detects distinct epitope polymorphism in human apo b (1985) (0)
- Identification of the major biological effect of ldl-in mediated immunosuppression of the primary immune response in vivo. Abstr. (1979) (0)
- IMMUNOSUPPRESSION BY NEONATAL APOLIPOPROTEIN E (1984) (0)
- Lipoprotein regulation of lh-stimulated androgen production by theca-interstitial cells (1984) (0)
- Estradiol selectivity inhibits oxidation of HDL (1994) (0)
- 4.P.378 HDL has anticoagulant cofactor activity for the protein C pathway (1997) (0)
- The monoclonal paratopic molecule and is for use in hybridoma-secreting Apolipoprotein AI for the determination of (1987) (0)
- Activated Platelets Induce Cholesteryl Ester Accumulation in Monocyte-Derived Macrophages and THP-1 Cells (1990) (0)
- TwoNewMonoclonal Antibody-Based Enzyme-Linked Assaysof Apolipoprotein B (1986) (0)
- Human Apolipoprotein Bsp cific Hybridoma Antibodies 15215 (2001) (0)
- directed against different domains of complement, C1, by monoclonal antibodies Activation of the first component of human (2001) (0)
- The monitor foerfarande Foer bestaemning of stabilt glucohemoglobin (1987) (0)
- The immunoregulatory plasma lipoprotein, ldl-in, is a set of intermediate density lipoprotein: immunochemical evidence using monoclonal antibodies. Abstr. (1981) (0)
- Regulation of Pathways of Lymphocyte Differentiation by the Serum Lipoprotein: LDL-In (1980) (0)
- Cholesterol, Apolipoprotein E, and Immune Cell Function (2020) (0)
- specific monoclonal antibodies of apolipoprotein B, produced by two new hybridomas. (1987) (0)
- Immunochemical method for the determination of stable glycosylated hemoglobin and diagnostic system for use in this method, Sam (1987) (0)
- Lipoprotein-Associated Phospholipase A2 and Cardiovascular Risk: State of the Evidence and Future Directions (2005) (0)
- Abstract 42: Monocyte Tissue Factor-Dependent Activation of Coagulation in Hypercholesterolemic Mice and Monkeys Is Inhibited by Simvastatin (2012) (0)
- of a Lymphocyte Surface Receptor for Low Density Lipoprotein Inhibitor, an Immunoregulatory Species of Normal Human Serum Low (1977) (0)
- 1SY02-3 Innate immunity in atherosclerosis (2003) (0)
- Multivalent Peptide-Mimetics of Apolipoprotein A-I That Modulate HDL Particles to Combat Atherosclerosis (2013) (0)
- Immunochemical method for determination of stable glycosylated hemoglobin. (1987) (0)
- Abstract 1518: Exacerbated Atherosclerosis in CD36 Null Mice may be due to Decreased Titers of IgM Antibodies that Bind Oxidized Low-Density Lipoproteins (2006) (0)
- High Density Lipoprotein-Specific Monoclonal Antibodies (1985) (0)
- Analytical method and diagnostic kit for the study of abnormal lipid metabolism (1987) (0)
- Generation of region‐specific antibodies to modified proteins (1987) (0)
- 1P-0267 Role of macrophages in the unique atherosclerotic lesion morphology of LDL receptor-deficiet mice with a Lystbeige mutation (2003) (0)
- Monoclonal paratopic molecules, hybridomas producing these molecules and their use in determining the apoli (1987) (0)
- 2009 George L. Duff Memorial Lecture--The Toll of Toll-Like Receptors on Atherosclerosis (2009) (0)
- Novel Agents that Prevent Atherosclerosis: Multivalent Peptide Constructs and Self-Assembling Cyclic DL-α-Peptides (2015) (0)
- Method for testing immune glycated hemoglobin stable. (1987) (0)
- Polypeptidanaloger of apolipoprotein E, diagnostisk System Science metoder aer industry analoger anvaends. (1992) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Linda K. Curtiss?
Linda K. Curtiss is affiliated with the following schools: